ABATE, DAVIDE ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.570
EU - Europa 478
AS - Asia 146
AF - Africa 3
SA - Sud America 2
OC - Oceania 1
Totale 3.200
Nazione #
US - Stati Uniti d'America 2.565
IT - Italia 161
DE - Germania 144
CN - Cina 117
FI - Finlandia 57
RU - Federazione Russa 28
GB - Regno Unito 27
SE - Svezia 23
UA - Ucraina 18
VN - Vietnam 16
IN - India 11
FR - Francia 8
NL - Olanda 4
IE - Irlanda 3
MX - Messico 3
CA - Canada 2
MA - Marocco 2
BE - Belgio 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
MG - Madagascar 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
Totale 3.200
Città #
Fairfield 385
Ann Arbor 276
Woodbridge 274
Houston 265
Chandler 211
Ashburn 191
Cambridge 189
Wilmington 153
Seattle 136
Jacksonville 72
Padova 61
Princeton 49
Beijing 44
San Diego 41
Aprilia 31
Helsinki 31
Medford 28
Des Moines 23
Guangzhou 22
Boardman 19
New York 19
Dong Ket 16
Nanjing 15
Ahmedabad 8
London 8
Falls Church 5
Jiaxing 5
Bergamo 4
Hebei 4
Milan 4
Norwalk 4
Spinea 4
Washington 4
Amsterdam 3
Dublin 3
Kharkiv 3
Nanchang 3
Pietro 3
Redwood City 3
Shenyang 3
Arce 2
Casablanca 2
Changsha 2
Columbus 2
Florence 2
Hanover 2
Jinan 2
Marano Di Napoli 2
North York 2
Nürnberg 2
Ogden 2
Paris 2
Pianiga 2
Rovigo 2
Verona 2
Vicenza 2
Zhengzhou 2
Acton 1
Adria 1
Ardabil 1
Auckland 1
Bari 1
Brussels 1
Castelfranco Veneto 1
Chicago 1
Chiswick 1
Cochabamba 1
Costa Mesa 1
Crotone 1
Duncan 1
Düsseldorf 1
Falkenstein 1
Fuzhou 1
Genova 1
Guidonia 1
Gunzenhausen 1
Hangzhou 1
Hefei 1
Kilburn 1
Las Vegas 1
Latina 1
Leawood 1
Los Angeles 1
Manila 1
Marigliano 1
Moscow 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Piove Di Sacco 1
Prague 1
Pune 1
Quito 1
Rieti 1
San Mateo 1
San Prospero 1
Sant'elena 1
Southwark 1
Stockholm 1
Suri 1
Totale 2.699
Nome #
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 154
Delayed acquisition of high avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. 148
A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation. 138
A Prospective Study on the Predictive Value of Plasma BK Virus-DNA Load for Hemorrhagic Cystitis in Pediatric Patients After Stem Cell Transplantation 137
Burkholderia cepacia complex isolation in non-polypoid chronic rhinosinusitis 131
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection 131
Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not cmv quantiferon assay is a novel biomarker to determine risk of congenital cmv infection in pregnant women 121
Optimization of Interferon gamma ELISPOT assay to detect Human Cytomegalovirus specific T-cell responses in solid organ transplants 120
Avidity of immunoglobulin G directed against human Cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. 118
Cytomegalovirus infection in pregnancy: a still complicated diagnostic problem 117
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated with Increased Risk of Fetal Infection in Primarily Infected Pregnant Women 112
Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV QuantiFERON cell-mediated immune assays in CMV-seropositive and -seronegative pregnant and nonpregnant women 108
Testing for cytomegalovirus in pregnancy 105
High Cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy. 104
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. 100
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients. 95
Diagnostic Utility of Human Cytomegalovirus-Specific T-Cell Response Monitoring in Predicting Viremia in Pediatric Allogeneic Stem-Cell Transplant Patients 93
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. 93
P761 * Antibody mediated rejection related with CMV and EBV infection in heart transplants recipients: a possible relation with infection and complement activation. 93
The third international consensus guidelines on the management of cytomegalovirus in solid organ transplantation 83
Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasis. 82
Effects of TNF-Alpha Inhibitors on Circulating Th17 Cells in Patients Affected by Severe Psoriasis 80
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. 79
CMV SPECIFIC IMMUNE RECONSTITUTION IN HTx PATIENTS TREATED WITH PRE-EMPTIVE STRATEGY: LIGHTS AND SHADOWS 78
null 65
Interaction of CMV Prophylaxis and Pre-Emptive Strategies with Immunosuppressive Therapy: Potential Antiviral Effect of Everolimus 64
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 61
Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: Is any question settled? 60
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents IRF-3 activation in the interferon response. 56
EVALUATION OF CMV SPECIFIC T-CELL RESPONSE IN HEART TRANSPLANT RECIPIENTS 50
Multicenter quality control study for human cytomegalovirus DNAemia quantification 49
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 47
Risk of varicella-zoster virus (VZV) infection in patients treated with TNFα blockers: Rationale for evaluation of the impact of anti-TNFα treatment on VZV-specific T-cell immunity in psoriasis patients 45
The First 90 Days: Temporary Effect of Alemtuzumab on CMV Immune Reconstitution 44
Multicenter quality control study for humancytomegalovirus DNAemia quantification 28
Monitoraggio di pazienti in trattamento per Citomegalovirosi AIDS-correlata mediante il test dell'antigenemia pp65 27
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. 15
Four-Year Follow-Up of the Maternal Immunological, Virological and Clinical Settings of a 36-Year-Old Woman Experiencing Primary Cytomegalovirus Infection Leading to Intrauterine Infection 8
Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients 5
Totale 3.244
Categoria #
all - tutte 10.670
article - articoli 10.670
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019167 0 0 0 0 0 0 0 0 0 0 88 79
2019/2020579 70 15 5 25 65 57 55 74 75 67 49 22
2020/2021620 82 61 40 39 40 33 12 52 124 23 65 49
2021/2022539 14 72 59 27 36 19 33 57 30 7 61 124
2022/2023454 75 43 19 44 85 53 0 30 67 15 20 3
2023/2024177 3 34 29 14 15 33 13 23 6 7 0 0
Totale 3.244